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1. Introduction 
During the maturation of reticulocytes the mito- 
chondria are lyzed and inactivated by a cell-specific 
lipoxygenase (LOX) [ 11. In addition to oxygenation 
of mitochondrial phospholipids the LOX action gives 
rise to an inhibition of the respiratory chain at three 
sites. Two inhibitory sites are located between the 
Fe-S centers of complex I and complex II and ubiqui- 
none [2]. The third inhibitory site located at the cyto- 
chrome c oxidase differs from the others with respect 
to the kinetics, dose-dependence and the extent of 
the inhibition [3,4]. The present paper deals with the 
mechanism of the inhibitory action of reticulocyte 
LOX on particulate cytochrome c oxidase. As reported 
elsewhere, even extensive LOX-treatment of submito- 
chondrial particles (SMP) does not affect the amount 
and the spectral properties of the redox-active compo- 
nents of the cytochrome c oxidase [ 1,2], which rules 
out the possibility of co-oxidative destruction of these 
components. In this paper evidence will be adduced 
that LOX inhibits cytochrome c oxidase by chemical 
modification of the membrane phospholipids which 
are essential for its activity. 
2. Materials and methods 
Beef heart mitochondria, SMP and Keilin-Hartree 
heart muscle preparation were prepared by standard 
methods [5,6]. LOX was purified from rabbit reticulo- 
cytes [l] and from soybeans [7]. The extraction of 
phospholipids from untreated and LOX-treated mito- 
Abbreviation: TMPD,N,N,iV’,N’-tetramethylp-phenylenedi- 
amine 
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chondria was performed both with acetone-water 
95:s [8] and with chloroform-methanol-O.1 M KC1 
10:5 :3 [9] under nitrogen purified by both alkaline 
pyrogallol and BTS catalyzer (Fluka AG, Switzerland). 
For the reactivation experiments 40 mg phospholipids 
were suspended in 4 ml 0.02 M Tris-acetate contain- 
ing 1 mM EDTA (pH 8 .O) and sonified 3 times for 
3 min with cooling under nitrogen (tip-type sonifier, 
Branson Sonic Power Co., USA, microtip); the suspen- 
sion was centrifuged at 15 000 rev./min for 20 min 
(Sorvall SS 3, Sorvall-DuPont , USA). Phospholipids 
from soybeans (Asolectin, commercial grade, type II-S, 
Sigma, USA) and Tween 80 (Atlas-Powder Co. USA) 
were used without further purification. 
Thin-layer chromatography (TLC) of the phospho- 
lipids was performed according to [ 111. Cytochrome c 
oxidase activity was assayed both spectrophotometri- 
tally using ferrocytochrome c (Serva, FRG) [lo] and 
polarographically using ascorbate/TMPD [ 121 in 0.1 M 
potassium phosphate, pH 7.4 at 37°C. Protein concen- 
trations were determined by the Biuret method [ 131. 
3. Results 
Table 1 shows the reversal of the LOX-mediated 
inhibition of cytochrome c oxidase by subsequent 
treatment with soybean phospholipids or Tween 80. 
The phospholipids restored the activity completely, 
whereas Tween 80 produced only partial reactivation. 
These results are in good agreement with those of Vik 
and Capaldi who used cytochrome c oxidase depleted 
of endogenous lipid by detergent exchange [ 141. Sim- 
ilar results (not shown) were obtained with SMP and 
with Keilin-Hartree heart muscle preparations. With 
LOX-treated SMP soybean phospholipid caused even 
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Table 1 
Reversal of inhibition of cytochrome c oxidase in mitochon- 





Cytochrome c oxidase 




(5 mglml) 0.445 
1% Tween 80 0.280 
3% Tween 80 0.300 
The mitochondria (2.6 mg protein) were preincubated twice 
with 5 mg LOX each at 37°C for 30 min (final vol. 0.3 ml in 
0.25 M sucrose/lo.6 mM K,HPO,). 5 ~1 of the diluted (1:30) 
preincubation sample were added to the reactivation sample 
(200 ~1) containing soybean phospholipid or Tween 80 in the 
final concentration as indicated. After incubation at 30°C for 
10 min the cytochrome c oxidase activity was measured at 
37°C spectrophotometrically (mean values of triplicate assay) 
additional activation as compared with the control of 
untreated SMP (table 2). This additional activation 
was observed, however, only when the activity was 
measured with external ferrocytochrome c, but not 
with ascorbate/TMPD as electron donor (table 3). 
This may indicate that LOX treatment with subse- 
quent phospholipid treatment improves the accessibil- 
ity of the SMP to external ferrocytochrome c, which 
is hindered in ‘inside out’ vesicles normally present in 
SMP preparations. The cytochrome c oxidase activity 
of LOX-treated SMP was also restored with native 
Table 2 






Cytochrome c oxidase 





MPL (LOX) 0.100 
SMP (0.2 mg protein) were preincubated twice with 2.5 mg 
LOX each at 37°C for 30 min (final vol. 0.2 ml in 0.25 M 
sucrose/lo.6 mM K,HPO,). 10 ~1 of the preincubation sam- 
ple were subjected to reactivation by 1 mg phospholipid as 
indicated in table 1 
Abbreviations: Soy-PL, soybean phospholipids; MPL, mito- 
chondrial phospholipids; MPL (LOX), phospholipids of LOX- 
treated mitochondria 
mitochondrial phospholipids. In contrast, a phospho- 
lipid extract of LOX-treated mitochondria failed to 
restore the activity (table 2). TLC of the phospholip- 
ids of LOX-treated mitochondria revealed a strong 
decrease in the share of phosphatidyl ethanolamine 
which is known to have a high content of arachidonic 
acid [ 151; on the other hand, the content of strongly 
polar non-migrating compounds was enhanced. The 
phospholipid extract did not gave a positive reaction 
with thiobarbituric acid indicating that the reaction 
of the LOX did not stop at hydroperoxides but led 
Table 3 




Addition for reactivation 
1 mM SHAM Phospholipid 
Cytochrome c oxidase activity on 
Asc./TMPD Ferrocyt. c 
AC, [mmol/min] aA sso/min 
_ _ _ 0.158 
t _ _ 0.090 
- t - 72 0.175 
+ + _ 30 0.080 
_ t t 50 0.100 
t + t 49 0.275 
SMP (0.22 mg protein) were preincubated with 2.5 mg LOX at 37°C for 30 mm under occa- 
sional shaking (final vol. 200 ~1 in 0.25 M sucrose/lOd mM K,HPO,) then SHAM was added 
and incubated for another 5 min. Reactivation by 100 mg soybean phospholipid/mg SMP pro- 
tein was performed as indicated in table 1. The reactivated SMP were washed in sucrose medium 
and resuspended in 200 ~I.50 or 10 nl were added to the asc./TMPD or ferrocytochrome c sys- 
tem, respectively 
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further to the formation of non-peroxidic products. 
A reactivation of the cytochrome c oxidase by 
phospholipids in LOX-treated mitochondria was also 
observed after extraction with acetone-water 95:5 
which is known to remove 70-75% of the total mito- 
chondrial phospho~pid [ 161. Reconstitution with 
native phospholipids after acetone extraction led to a 
comparable reactivation of LOX-treated and untreated 
mitochondria. The total lipid extract of LOX-treated 
mitochondria after addition of fresh LOX exhibited 
only 7% of the oxygen uptake as compared with that 
of the lipid extract of untreated mito~hondria. On the 
other hand, the acetone-treated mitochondria showed 
only a negligible oxygen uptake after addition of LOX 
in contrast to nonextracted mitochondria, although 
the acetone-treated mitochondria retained -20% of 
their original cytochome c oxidase activity. This sug 
gests that acetone extraction removes that portion of 
mitochondrial phospholipids which is also accessible 
to LOX. In contrast to the cytochrome c oxidase 
activity the succinate-cytochrome c oxidoreductase 
activity of LOX-treated mitochondria could not be 
restored by phospho~pids plus ubiqu~one-50 either 
with or without acetone-treatment. The action of 
LOX on the succinate-ubiquinone oxidoreductase 
system is obviously not restricted to the phospholipid 
moiety, but leads secondarily to irreversible damage 
of protein components. 
The reversal by phospho~pids of the LOX-medi- 
ated inhibition of the cytochrome c oxidase in SMP 
required an -250-fold excess of added phosphoiipids 
as referred to the endogenous phospholipid content. 
Only partial reactivation was observed with half the 
amount. 
Table 3 shows that the site of both inhibition by 
LOX and the subsequent reactivation by phospholip- 
ids is the cytochrome c oxidase complex per se rather 
than its interaction with external ferrocytochrome c, 
since identical results were obtained with the ascor- 
bate/TMPD oxidase system which works without 
external cytochrome c. In this experiment an addition 
of the LOX inhibitor salicyihydroxamic acid (SHAM) 
after the LOX-treatment was necessary in order to 
avoid an interference by LOX-mediated oxygen uptake 
upon the addition of phospholipid in the polarographic 
assay. An addition of SHAM before LOX treatment 
prevented totally the inhibition of cytochrome c oti- 
dase as measured polarographically (not shown). The 
partial inhibition of the untreated SMP by phospho- 
lipid may be due to their content of free fatty acids 
(detected by TLC) which are abfe to inhibit the cyto- 
chrome c oxidase [ 171. 
In contrast to reticulocyte LOX a comparable 
amount of soybean LOX-1 as referred to the activity 
on linoleate as substrate failed to produce both oxy- 
gen uptake with mitochondria or inhibition of cyto- 
chrome c oxidase. 
4, Discussion 
This report demonstrates the reversib~ity of the 
inhibition of cytochrome c oxidase by LOX and rules 
out the possibility of a secondary damage of polypep- 
tide components of the cytochrome c oxidase com- 
plex. The mechanism of the reversal by phospholipids 
may be explained on the basis of the recent findings 
by Schneider et al., who have demonstrated a fusion 
of soybean phospholipid liposomes with mitochon- 
drial inner membranes [ 181. The high excess of phos- 
pholipid necessary for reactivation in our experiments 
may be due to the unfavorable conditions for such a 
fusion (e g ., pH 7.4 instead of 6 S). The added phos- 
pholipids which are incorporated in the LOX-treated 
inner mitochondrial membranes displace presumably 
the phospholipids modified by LOX and thus restore 
the lipid environment needed for the activity of the 
cytochrome c oxidase system. The reverse action, i.e., 
a dispIa~ement of phospholipids by the inactive modi- 
fied ones is suggested in experiments where they were 
added (not shown). The attack of LOX on the fatty 
acid moiety of phospholipids has two consequences: 
(i) A lowering of the hydrophobicity owing to the 
introduction of hydroperoxy or (secondar~y) 
hydroxy- and other hydroph~ic-groups; 
(ii) A decrease in the membrane fluidity. 
The first effect weakens the hydrophobic interactions 
with catalytic proteins which are essential for their 
activity. As far as the fluidity of the phospholipids is 
concerned, Vik and Capaldi have shown in their recon- 
stitution experiments, that substitution of saturated 
phospholipids for the dioleyl derivatives or natural 
phospholipids reduces the cytochrome c oxidase activ- 
ity by at least SO%, whereas the polar group is of 
minor importance. 
The reticulocyte LOX has turned out to be an 
interesting tool for the study of phospholipid-depen- 
dent enzymes. 
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